CLOFARABINA ACCORDN 1mg / ml concentrate for solution for infusion medication leaflet

L01BB06 • clofarabine • Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues

Clofarabine is an antineoplastic agent used for the treatment of acute lymphoblastic leukemia in children and young adults who have not responded to other therapies. It works by inhibiting DNA and RNA synthesis in cancer cells, thereby preventing their proliferation.

The medication is administered intravenously, as directed by a doctor, usually as part of a treatment cycle. It is important for patients to undergo regular check-ups to monitor hematologic function and other effects of the therapy.

Patients should be aware of potential side effects, such as nausea, fever, or decreased blood cell counts. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, fever, and decreased blood cell counts. In rare cases, severe reactions such as liver failure or severe infections may occur. Patients should be informed of these risks before use.